|
AP9528a-ev
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
|
AP9528a
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
|
AM8494b-ev
|
Abcepta, Inc.
|
VCP [1563CT163.48.77], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC-P, FC, IF
|
|
|
AM8494b
|
Abcepta, Inc.
|
VCP [1563CT163.48.77], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC-P, FC, IF
|
|
|
AP23051PU-N
|
OriGene Technologies
|
FMRP (FMR1) (594-607), Goat Polyclonal Antibody
|
Bat, Hamster, Human, Monkey, Mouse, Porcine, Rabbit, Rat
|
ELISA, IHC, WB
|
|
|
GTX33966
|
GeneTex International Corporation
|
GLCNE, Rabbit Polyclonal Antibody
|
Mouse
|
ELISA, IHC, WB
|
|
|
GTX128120
|
GeneTex International Corporation
|
Porcine circovirus type 2 / PCV2 Capsid, Rabbit Polyclonal Antibody
|
Porcine circovirus type 2
|
IHC, IHC-P, WB
|
|
|
GTX128120-S
|
GeneTex International Corporation
|
Porcine circovirus type 2 / PCV2 Capsid, Rabbit Polyclonal Antibody
|
Porcine circovirus type 2
|
IHC, IHC-P, WB
|
|
|
GTX128121
|
GeneTex International Corporation
|
Porcine circovirus type 2 / PCV2 Capsid, Rabbit Polyclonal Antibody
|
Pig, Porcine circovirus type 2
|
IHC-P, WB
|
|
|
GTX128121-S
|
GeneTex International Corporation
|
Porcine circovirus type 2 / PCV2 Capsid, Rabbit Polyclonal Antibody
|
Pig, Porcine circovirus type 2
|
IHC-P, WB
|
|
|
HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-13440-1mg
|
MedChemexpress LLC
|
AMG 511 [CAS 1253573-53-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-13440-5mg
|
MedChemexpress LLC
|
AMG 511 [CAS 1253573-53-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-13440-1mL
|
MedChemexpress LLC
|
AMG 511 [CAS 1253573-53-3] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-19502-1mg
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19502-10mg
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19502-100mg
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19502-5mg
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19502-50mg
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-19502-1mL
|
MedChemexpress LLC
|
Artemisone [CAS 255730-18-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13832-10mg
|
MedChemexpress LLC
|
Atovaquone [CAS 95233-18-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13832-5mg
|
MedChemexpress LLC
|
Atovaquone [CAS 95233-18-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13832-50mg
|
MedChemexpress LLC
|
Atovaquone [CAS 95233-18-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-13832-1mL
|
MedChemexpress LLC
|
Atovaquone [CAS 95233-18-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
